Cargando…

Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment

There are limited reports regarding early predictors of objective response (OR) in patients with hepatocellular carcinoma (HCC) treated with lenvatinib. This retrospective study including 70 patients aimed to investigate the efficacy of hepatic biochemical markers. Changes in tumor marker (alpha-fet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeki, Issei, Yamasaki, Takahiro, Yamashita, Satoyoshi, Hanazono, Tadasuke, Urata, Yohei, Furutani, Takakazu, Yokoyama, Yuichiro, Oishi, Toshiyuki, Maeda, Masaki, Kimura, Teruaki, Kotoh, Yurika, Sasaki, Ryo, Miyaji, Takashi, Oono, Takashi, Aibe, Yuki, Hisanaga, Takuro, Iwamoto, Takuya, Matsumoto, Toshihiko, Hidaka, Isao, Ishikawa, Tsuyoshi, Takami, Taro, Sakaida, Isao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225985/ https://www.ncbi.nlm.nih.gov/pubmed/32218295 http://dx.doi.org/10.3390/cancers12040779

Ejemplares similares

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2019)

A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2019)

Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma
por: Tanabe, Norikazu, et al.
Publicado: (2023)

Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report
por: Iwamoto, Takuya, et al.
Publicado: (2019)

Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2020)

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
por: Saeki, Issei, et al.
Publicado: (2018)

A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
por: Saeki, Issei, et al.
Publicado: (2015)

Novel Liquid Biopsy Test Based on a Sensitive Methylated SEPT9 Assay for Diagnosing Hepatocellular Carcinoma
por: Kotoh, Yurika, et al.
Publicado: (2020)

Assessment of high-fat-diet-induced fatty liver in medaka
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
por: Saeki, Issei, et al.
Publicado: (2016)

TNFR1-mediated signaling is important to induce the improvement of liver fibrosis by bone marrow cell infusion
por: Hisanaga, Takuro, et al.
Publicado: (2011)

Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model
por: Nishimura, Tatsuro, et al.
Publicado: (2019)

Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
por: Yamamoto, Naoki, et al.
Publicado: (2016)

Iron regulation by hepatocytes and free radicals
por: Takami, Taro, et al.
Publicado: (2011)

Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma
por: Saeki, Issei, et al.
Publicado: (2021)

Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015)

Correction: Evidence for a Role of the Transcriptional Regulator Maid in Tumorigenesis and Aging
por: Fujisawa, Koichi, et al.
Publicado: (2015)

Improved Hepatic Reserve and Fibrosis in a Case of “Portal-Systemic Liver Failure” by Portosystemic Shunt Occlusion
por: Ishikawa, Tsuyoshi, et al.
Publicado: (2020)

Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment
por: Yamasaki, Takahiro, et al.
Publicado: (2022)

Cost-effectiveness of a “treat-all” strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages
por: Suenaga, Riichiro, et al.
Publicado: (2021)

Analysis of the safety of pretransplant corticosteroid therapy in patients with acute liver failure and late‐onset hepatic failure in Japan
por: Hisanaga, Takuro, et al.
Publicado: (2021)

A canine liver fibrosis model to develop a therapy for liver cirrhosis using cultured bone marrow–derived cells
por: Matsuda, Takashi, et al.
Publicado: (2017)

EUS-guided biliary drainage in a patient after postcholecystectomy complete biliary transection (with video)
por: Suehiro, Harumi, et al.
Publicado: (2022)

Profiling of the circadian metabolome in thioacetamide‐induced liver cirrhosis in mice
por: Fujisawa, Koichi, et al.
Publicado: (2017)

Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
por: Sakaida, Takashi, et al.
Publicado: (2020)

Correction: Medaka as a model for human nonalcoholic steatohepatitis
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
por: Tanabe, Norikazu, et al.
Publicado: (2017)

Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells
por: Fujisawa, Koichi, et al.
Publicado: (2020)

An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells
por: Fujisawa, Koichi, et al.
Publicado: (2022)

Iron-rich Kupffer cells exhibit phenotypic changes during the development of liver fibrosis in NASH
por: Kanamori, Yohei, et al.
Publicado: (2021)

Circadian variations in the liver metabolites of medaka (Oryzias latipes)
por: Fujisawa, Koichi, et al.
Publicado: (2016)

Evaluation of the effects of ascorbic acid on metabolism of human mesenchymal stem cells
por: Fujisawa, Koichi, et al.
Publicado: (2018)

Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver
por: Fujisawa, Koichi, et al.
Publicado: (2017)

Trans-portal hepatic infusion of cultured bone marrow-derived mesenchymal stem cells in a steatohepatitis murine model
por: Sasaki, Ryo, et al.
Publicado: (2020)

Seasonal variations in photoperiod affect hepatic metabolism of medaka (Oryzias latipes)
por: Fujisawa, Koichi, et al.
Publicado: (2021)

Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation
por: Kuwashiro, Shinya, et al.
Publicado: (2011)

Efficacy of lenvatinib in a patient with anaplastic thyroid cancer
por: Oishi, Kazuyuki, et al.
Publicado: (2017)

Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer
por: Hideura, Eizaburou, et al.
Publicado: (2020)

Trigeminal Root Entry Zone Lesions in Non-multiple Sclerosis
por: Matsumoto, Arifumi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pi0stb3vmc482r1nsiandgv353